-
T597237-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Azide, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595082-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-NHS ester, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595082-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-NHS ester, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595082-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-NHS ester, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595111-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Propargyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595111-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Propargyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595111-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Propargyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595825-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-t-butyl ester, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595825-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-t-butyl ester, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595825-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-t-butyl ester, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595108-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG5-Tosyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595108-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG5-Tosyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.